FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1993913184> ?p ?o ?g. }

• W1993913184 endingPage "1149" @default.
• W1993913184 startingPage "1142" @default.
• W1993913184 abstract "Objectives To compare the prevalence, symptoms, and pathologic changes related to chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) with significant prostatitis-like symptoms between 2 altitude areas in northwest China. Methods From October 2009 to March 2010 community male residents at 3000 m (Delingha) and 400 m (Xi'An) constituted the population base for the present cross-sectional study. All participants completed a detailed questionnaire containing the National Institutes of Health Chronic Prostatitis Symptom Index, and the subjects who met our definition were invited to undergo clinical evaluation. After screening, the subjects considered to have CP/CPPS were separated into 2 groups: those with type IIIa and those with type IIIb CP/CPPS. Results The prevalence of CP/CPPS with significant prostatitis-like symptoms was significantly different between the 2 groups. Moreover, the National Institutes of Health Chronic Prostatitis Symptom Index of patients with type IIIa and IIIb in 2 groups differed significantly, indicating the aggravation of symptoms of CP/CPPS at a high altitude. Additional investigations showed that reactive oxygen species were increased, accompanied by a decrease in the total antioxidant capacity in the expressed prostatic secretions of patients with type IIIa at a higher altitude. In addition, the tumor necrosis factor-α, interleukin-8, and interleukin-10 levels in the expressed prostatic secretions of patients with type IIIa in Delingha were increased compared with that in the patients with type IIIa in Xi'An. Notably, the interleukin-6 level in the expressed prostatic secretions was greater in those with type IIIa and IIIb at a higher altitude than in those with type IIIa and IIIb at a low altitude. Conclusions At a high altitude, the symptoms of CP/CPPS were aggravated. Oxidative stress and cytokines might involve in the pathologic process and the aggravation of symptoms. In addition, in a high altitude area the pathomechanisms of type IIIa and IIIb CP/CPPS differed. To compare the prevalence, symptoms, and pathologic changes related to chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) with significant prostatitis-like symptoms between 2 altitude areas in northwest China. From October 2009 to March 2010 community male residents at 3000 m (Delingha) and 400 m (Xi'An) constituted the population base for the present cross-sectional study. All participants completed a detailed questionnaire containing the National Institutes of Health Chronic Prostatitis Symptom Index, and the subjects who met our definition were invited to undergo clinical evaluation. After screening, the subjects considered to have CP/CPPS were separated into 2 groups: those with type IIIa and those with type IIIb CP/CPPS. The prevalence of CP/CPPS with significant prostatitis-like symptoms was significantly different between the 2 groups. Moreover, the National Institutes of Health Chronic Prostatitis Symptom Index of patients with type IIIa and IIIb in 2 groups differed significantly, indicating the aggravation of symptoms of CP/CPPS at a high altitude. Additional investigations showed that reactive oxygen species were increased, accompanied by a decrease in the total antioxidant capacity in the expressed prostatic secretions of patients with type IIIa at a higher altitude. In addition, the tumor necrosis factor-α, interleukin-8, and interleukin-10 levels in the expressed prostatic secretions of patients with type IIIa in Delingha were increased compared with that in the patients with type IIIa in Xi'An. Notably, the interleukin-6 level in the expressed prostatic secretions was greater in those with type IIIa and IIIb at a higher altitude than in those with type IIIa and IIIb at a low altitude. At a high altitude, the symptoms of CP/CPPS were aggravated. Oxidative stress and cytokines might involve in the pathologic process and the aggravation of symptoms. In addition, in a high altitude area the pathomechanisms of type IIIa and IIIb CP/CPPS differed." @default.
• W1993913184 created "2016-06-24" @default.
• W1993913184 creator A5012491375 @default.
• W1993913184 creator A5016514365 @default.
• W1993913184 creator A5021471823 @default.
• W1993913184 creator A5026060144 @default.
• W1993913184 creator A5032605347 @default.
• W1993913184 creator A5052780403 @default.
• W1993913184 creator A5057209439 @default.
• W1993913184 creator A5065254789 @default.
• W1993913184 creator A5065935918 @default.
• W1993913184 creator A5085300055 @default.
• W1993913184 date "2011-11-01" @default.
• W1993913184 modified "2023-09-22" @default.
• W1993913184 title "Influence of Environmental Factors on Prevalence, Symptoms, and Pathologic Process of Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Northwest China" @default.
• W1993913184 cites W1552119358 @default.
• W1993913184 cites W1873122846 @default.
• W1993913184 cites W1966474913 @default.
• W1993913184 cites W1975001819 @default.
• W1993913184 cites W1975401806 @default.
• W1993913184 cites W1991506866 @default.
• W1993913184 cites W1996299251 @default.
• W1993913184 cites W1997799256 @default.
• W1993913184 cites W1997955063 @default.
• W1993913184 cites W1998761071 @default.
• W1993913184 cites W2003482728 @default.
• W1993913184 cites W2004274286 @default.
• W1993913184 cites W2025729794 @default.
• W1993913184 cites W2027311687 @default.
• W1993913184 cites W2040798098 @default.
• W1993913184 cites W2044658094 @default.
• W1993913184 cites W2065686737 @default.
• W1993913184 cites W2074953874 @default.
• W1993913184 cites W2079612728 @default.
• W1993913184 cites W2091064143 @default.
• W1993913184 cites W2097199316 @default.
• W1993913184 cites W2108390694 @default.
• W1993913184 cites W2121672362 @default.
• W1993913184 cites W2167442982 @default.
• W1993913184 doi "https://doi.org/10.1016/j.urology.2011.04.066" @default.
• W1993913184 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22054390" @default.
• W1993913184 hasPublicationYear "2011" @default.
• W1993913184 type Work @default.
• W1993913184 sameAs 1993913184 @default.
• W1993913184 citedByCount "14" @default.
• W1993913184 countsByYear W19939131842012 @default.
• W1993913184 countsByYear W19939131842013 @default.
• W1993913184 countsByYear W19939131842016 @default.
• W1993913184 countsByYear W19939131842018 @default.
• W1993913184 countsByYear W19939131842020 @default.
• W1993913184 countsByYear W19939131842021 @default.
• W1993913184 countsByYear W19939131842023 @default.
• W1993913184 crossrefType "journal-article" @default.
• W1993913184 hasAuthorship W1993913184A5012491375 @default.
• W1993913184 hasAuthorship W1993913184A5016514365 @default.
• W1993913184 hasAuthorship W1993913184A5021471823 @default.
• W1993913184 hasAuthorship W1993913184A5026060144 @default.
• W1993913184 hasAuthorship W1993913184A5032605347 @default.
• W1993913184 hasAuthorship W1993913184A5052780403 @default.
• W1993913184 hasAuthorship W1993913184A5057209439 @default.
• W1993913184 hasAuthorship W1993913184A5065254789 @default.
• W1993913184 hasAuthorship W1993913184A5065935918 @default.
• W1993913184 hasAuthorship W1993913184A5085300055 @default.
• W1993913184 hasConcept C121608353 @default.
• W1993913184 hasConcept C126322002 @default.
• W1993913184 hasConcept C1862650 @default.
• W1993913184 hasConcept C2524010 @default.
• W1993913184 hasConcept C2776235491 @default.
• W1993913184 hasConcept C2776362571 @default.
• W1993913184 hasConcept C2780524745 @default.
• W1993913184 hasConcept C2908647359 @default.
• W1993913184 hasConcept C33923547 @default.
• W1993913184 hasConcept C6350597 @default.
• W1993913184 hasConcept C71924100 @default.
• W1993913184 hasConcept C90924648 @default.
• W1993913184 hasConcept C99454951 @default.
• W1993913184 hasConceptScore W1993913184C121608353 @default.
• W1993913184 hasConceptScore W1993913184C126322002 @default.
• W1993913184 hasConceptScore W1993913184C1862650 @default.
• W1993913184 hasConceptScore W1993913184C2524010 @default.
• W1993913184 hasConceptScore W1993913184C2776235491 @default.
• W1993913184 hasConceptScore W1993913184C2776362571 @default.
• W1993913184 hasConceptScore W1993913184C2780524745 @default.
• W1993913184 hasConceptScore W1993913184C2908647359 @default.
• W1993913184 hasConceptScore W1993913184C33923547 @default.
• W1993913184 hasConceptScore W1993913184C6350597 @default.
• W1993913184 hasConceptScore W1993913184C71924100 @default.
• W1993913184 hasConceptScore W1993913184C90924648 @default.
• W1993913184 hasConceptScore W1993913184C99454951 @default.
• W1993913184 hasIssue "5" @default.
• W1993913184 hasLocation W19939131841 @default.
• W1993913184 hasLocation W19939131842 @default.
• W1993913184 hasOpenAccess W1993913184 @default.
• W1993913184 hasPrimaryLocation W19939131841 @default.
• W1993913184 hasRelatedWork W163955934 @default.
• W1993913184 hasRelatedWork W2016529497 @default.
• W1993913184 hasRelatedWork W2157483319 @default.
• W1993913184 hasRelatedWork W2529656862 @default.

• next